Amneal Pharmaceuticals Inc’s recently made public that its 10% Owner Patel Tushar Bhikhubhai unloaded Company’s shares for reported $41.75 million on Mar 14 ’25. In the deal valued at $8.35 per share,5,000,000 shares were sold. As a result of this transaction, Patel Tushar Bhikhubhai now holds 48,578,209 shares worth roughly $431.86 million.
Then, Patel Tushar Bhikhubhai bought 5,000,000 shares, generating $43,750,000 in total proceeds.
Before that, BOYER ANDREW S sold 125,000 shares. Amneal Pharmaceuticals Inc shares valued at $1,111,250 were divested by the Executive Vice President at a price of $8.89 per share. As a result of the transaction, BOYER ANDREW S now holds 290,106 shares, worth roughly $2.58 million.
JP Morgan upgraded its Amneal Pharmaceuticals Inc [AMRX] rating to an Overweight from a a Neutral in a research note published on February 24, 2025; the price target was increased to $12 from $9. A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in early September from “an Underweight” to “a Neutral”. Goldman revised its rating on March 08, 2021. It rated AMRX as “a Buy” which previously was an “a Sell”.
Price Performance Review of AMRX
On Monday, Amneal Pharmaceuticals Inc [NASDAQ:AMRX] saw its stock jump 2.66% to $8.89. Over the last five days, the stock has gained 3.13%. Amneal Pharmaceuticals Inc shares have risen nearly 12.25% since the year began. Nevertheless, the stocks have risen 46.22% over the past one year. While a 52-week high of $9.48 was reached on 03/03/25, a 52-week low of $5.18 was recorded on 02/28/25. SMA at 50 days reached $8.39, while 200 days put it at $8.05.
Levels Of Support And Resistance For AMRX Stock
The 24-hour chart illustrates a support level at 8.76, which if violated will result in even more drops to 8.64. On the upside, there is a resistance level at 8.97. A further resistance level may holdings at 9.05. The Relative Strength Index (RSI) on the 14-day chart is 57.53, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 26.92%. Stochastics %K at 66.27% indicates the stock is a holding.
How much short interest is there in Amneal Pharmaceuticals Inc?
A steep rise in short interest was recorded in Amneal Pharmaceuticals Inc stocks on 2025-02-28, growing by 0.34 million shares to a total of 2.76 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 2.42 million shares. There was a rise of 12.38%, which implies that there is a positive sentiment for the stock.
